🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟 Celebrating Riverlane’s ingenious inventors! 🌟 At Riverlane, we’re very proud of our team’s incredible achievements. In 2024, we celebrated a remarkable year with patent applications for 24 new inventions! In total, we’ve filed patent applications for more than 50 different

Our Senior Director R&D, Feras, was delighted to host Vice Admiral Andrew Burns CB OBE, Royal Navy Fleet Commander & Durham alumnus, alongside Professor Kieran Fernandes & Stephen Evans from Durham University at NETPark, with a tour of our labs and overview of our #FlexIC technology

We are excited to continue our support for Cambridge GaN Devices (CGD) in its $32M Series C funding round, helping to drive the next generation of energy-efficient power electronics. At Cambridge Innovation Capital, we are invest in deeptech solutions that deliver both technological breakthroughs and

Versius has now been used to treat over 30,000 patients globally, solidifying its position as the second most utilised soft-tissue surgical robot on the market. Find out more about our latest clinical milestone with #Versius: bit.ly/3QteLuI #TransformingSurgery

30,000 surgical cases completed; 30,000 lives changed. #Versius has now been used to treat over 30,000 patients globally, solidifying its position as the second most utilised soft-tissue surgical robot on the market. Find out more: bit.ly/3QteLuI #TransformingSurgery

Great to see techUK launch their latest report, 'UK Plan for Chips' this week, with our CTO, Richard Price featuring in a roundtable alongside fellow industry leaders & government. Hear from Richard & download the full report in The Manufacturer below. themanufacturer.com/articles/new-b…

Backing UK Innovation with the £100M CIC Opportunity Fund 🚀 We’re pleased to launch the CIC Opportunity Fund, a £100 million growth fund anchored by Aviva Investors and British Patient Capital, with cornerstone commitments of £15 million and £20 million, respectively. This fund is

Today we reported recent business progress and fourth quarter and full year 2024 financial results. Read our press release here: bit.ly/4bhSKsL.

Check out the latest podcast from Tech Arena, 'Flexibility at the Edge', featuring our CEO David Moore, exploring how our unique flexible integrated circuits (FlexICs) are unlocking new edge AI and IoT applications. Listen to the episode (19 mins) here: techarena.ai/content/flexib…

Powering the Next Wave of UK Innovation 🚀 We’re excited to launch our £100 million CIC Opportunity Fund, backed by Aviva Investors and British Patient Capital. This fund will provide essential scale-up financing for the UK’s most promising deep tech and life sciences companies, helping

Andrew Williamson, Managing Partner at CIC, joined BBC Radio 4’s Today programme to discuss the Cambridge Innovation Capital Opportunity Fund and the critical need for scale-up capital. The conversation highlighted the groundbreaking technologies emerging from the Oxford-Cambridge Arc - innovations

🤔 Curious about QEC? In our latest blog post, our staff quantum scientist, Luka Skoric, explains why quantum computers need quantum error correction (QEC). Here's what you'll learn: 1️⃣ The QEC Problem: Why today's error rates are a major bottleneck for useful quantum

Powering the Next Wave of UK Innovation 🚀 We’re excited to launch our £100 million Cambridge Innovation Capital Opportunity Fund, backed by Aviva Investors and British Patient Capital. One of our first investments is Riverlane, the leading quantum error correction company partnering with many of the world's

Pension funds play a critical role in driving economic growth, and one untapped area for investment is university #spinouts 🚀 Join us at the PLSA Investment Conference in March to explore opportunities to invest in some of tomorrow’s global success stories today. Our

Real-time quantum error correction (QEC) is a critical capability that ensures logical qubits stay alive indefinitely, paving the way for scalable, fault-tolerant quantum computing. Today, we are excited to share two updates on how we’re helping our partners make significant

🤔 To reset or not to reset? That is the question... that our latest peer-reviewed paper answers in this month’s Nature’s NPJ Quantum Information journal. The paper identifies a commonly overlooked phenomenon: How does resetting qubits affect the performance of fault-tolerant

As featured on BBC News (UK), a four-month-old baby weighing just six kilogrammes is the youngest child in the world to successfully have surgery using #Versius, at MFT NHS Royal Manchester Children’s Hospital in a landmark clinical trial. Read more: bbc.co.uk/news/articles/…

We're thrilled #Versius plays a small part in the amazing work Calderdale and Huddersfield NHS Foundation Trust have done to reduce elective surgery waitlists! See their story on last night's BBC The One Show.

We are excited to announce new appointments to our Board of Directors & leadership team, including Felix Baker who will become our new chairman, Alessandro Riva who joins our Board and Fabrice Andre who joins our Clinical Advisory Board. Read more here: bit.ly/43YifNO

We're pleased to share that we have secured over $200 million in our latest financing round. The raise will accelerate commercial expansion of #Versius globally, with a major focus on launching the system in the U.S. following FDA approval. Find out more: bit.ly/3Yeoo4R